Table 1.
First author |
Year | Location | Sample size |
Source of participantsa |
Measure of exposureb |
Duration of exposure |
Measure of BMDc |
Matching and/or statistical adjustment |
Main findings |
---|---|---|---|---|---|---|---|---|---|
Coelho [7] | 1999 | Portugal | 102 | Community sample (only women), age: 40–80 yrs | BDI HSCL-90 | Current | Lumbar spine & femur DEXA | Adjusted for age and BMI | BMD≤−2.5 SD below reference mean (osteoporosis) assoc w/higher DepSx |
Reginster [22] | 1999 | Belgium | 121 | Outpatient clinic (only women), age: 48–77 yrs | GHQ | Current | Spine, total hip & femoral neck DEXA | Adjusted for age, menopause, weight, height, estrogen use | No assoc btw DepSx & BMD |
Robbins [12] | 2001 | USA | 1,566 | Population-based Medicare enrollees, age: 65–100 yrs | CESD-10 | Current | Total hip DEXA | Stratified by race and sex. Adjusted for age, BMI, kilocalories expended, estrogen use, smoking, alcohol intake | DepSx assoc w/lower BMD overall DepSx assoc w/lower BMD only among Caucasian women in stratified analyses |
Mussolino [18] | 2004 | USA | 5,171 | Population-based, age: 30–39 yrs | DIS | Lifetime | Total proximal femur DEXA | Statified by sex. Adjusted for age, race, weight, height, food energy, calcium intake, protein intake, alcohol intake, smoking, physical activity, chronic conditions, weight change | Men: Major depressive episode assoc w/lower BMD Women: No assoc btwn major depressive episode & BMD |
Whooley [23] | 2004 | USA | 515 | Population-based (only men), age: 50+yrs | GDS | Current | Lumbar spine & total hip DEXA | Adjusted for age, weight change, physical activity, smoking, caffeine intake, calcium use, steroid, diuretic, & benzodiazepine use, perceived health, BMI, chair stand activity | No assoc btwn DepSx & baseline BMD |
Wong [15] | 2005 | Hong Kong | 2,000 | Population based (only men), age: 65–92 yrs | GDS | Current | Lumbar spine, total hip & total body DEXA | Adjusted for age, weight, calcium intake, physical activity, antipressant use, smoking status, comorbid COPD and CVD | DepSx assoc w/lower total hip BMD DepSx assoc w/increased risk of T-score≤−1 |
Jacka [9] | 2005 | Australia | 78 | Community sample (only women), age: 45–60 yrs | Self-report DSM-based questionaire | ≤ 1 year | Lumbar spine & total hip | Adjusted for age, weight, estrogen use | DepSx assoc w/lower BMD |
Unless otherwise stated, studies include both men and women. Mean age of study participants is given if age range was unavailable.
Diagnostic measures of depression (MDD or MDE): DIS diagnostic interview schedule. Non-diagnostic measures of depressive symptoms (DepSx): BDI Beck depression inventory, HSCL-90 Hopkins symptom checklist-90, GHQ general health questionnaire, CESD-10 centers for epidemiologic studies depression scale-10 item. GDS geriatric depression scale. Self-report DSM based questionnaire.
DEXA dual-energy x-ray absorptiometry